Your browser doesn't support javascript.
loading
Targeting the epichaperome as an effective precision medicine approach in a novel PML-SYK fusion acute myeloid leukemia.
Sugita, Mayumi; Wilkes, David C; Bareja, Rohan; Eng, Kenneth W; Nataraj, Sarah; Jimenez-Flores, Reyna A; Yan, LunBiao; De Leon, Jeanne Pauline; Croyle, Jaclyn A; Kaner, Justin; Merugu, Swathi; Sharma, Sahil; MacDonald, Theresa Y; Noorzad, Zohal; Panchal, Palak; Pancirer, Danielle; Cheng, Shuhua; Xiang, Jenny Z; Olson, Luke; Van Besien, Koen; Rickman, David S; Mathew, Susan; Tam, Wayne; Rubin, Mark A; Beltran, Himisha; Sboner, Andrea; Hassane, Duane C; Chiosis, Gabriela; Elemento, Olivier; Roboz, Gail J; Mosquera, Juan Miguel; Guzman, Monica L.
Affiliation
  • Sugita M; Department of Medicine, Division of Hematology/Oncology, Weill Cornell Medicine, New York, NY, USA.
  • Wilkes DC; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and NewYork Presbyterian, New York, NY, USA.
  • Bareja R; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
  • Eng KW; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and NewYork Presbyterian, New York, NY, USA.
  • Nataraj S; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.
  • Jimenez-Flores RA; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.
  • Yan L; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and NewYork Presbyterian, New York, NY, USA.
  • De Leon JP; Department of Physiology and Biophysics, Weill Cornell Medicine, New York, NY, USA.
  • Croyle JA; Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY, USA.
  • Kaner J; Department of Medicine, Division of Hematology/Oncology, Weill Cornell Medicine, New York, NY, USA.
  • Merugu S; Department of Medicine, Division of Hematology/Oncology, Weill Cornell Medicine, New York, NY, USA.
  • Sharma S; Department of Medicine, Division of Hematology/Oncology, Weill Cornell Medicine, New York, NY, USA.
  • MacDonald TY; Department of Medicine, Division of Hematology/Oncology, Weill Cornell Medicine, New York, NY, USA.
  • Noorzad Z; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and NewYork Presbyterian, New York, NY, USA.
  • Panchal P; Department of Medicine, Division of Hematology/Oncology, Weill Cornell Medicine, New York, NY, USA.
  • Pancirer D; Department of Medicine, Division of Hematology/Oncology, Weill Cornell Medicine, New York, NY, USA.
  • Cheng S; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Xiang JZ; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Olson L; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and NewYork Presbyterian, New York, NY, USA.
  • Van Besien K; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and NewYork Presbyterian, New York, NY, USA.
  • Rickman DS; Chemical Biology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Mathew S; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and NewYork Presbyterian, New York, NY, USA.
  • Tam W; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and NewYork Presbyterian, New York, NY, USA.
  • Rubin MA; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and NewYork Presbyterian, New York, NY, USA.
  • Beltran H; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
  • Sboner A; Department of Medicine, Division of Hematology/Oncology, Weill Cornell Medicine, New York, NY, USA.
  • Hassane DC; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and NewYork Presbyterian, New York, NY, USA.
  • Chiosis G; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and NewYork Presbyterian, New York, NY, USA.
  • Elemento O; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
  • Roboz GJ; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
  • Mosquera JM; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY, USA.
  • Guzman ML; Caryl and Israel Englander Institute for Precision Medicine, Weill Cornell Medicine and NewYork Presbyterian, New York, NY, USA.
NPJ Precis Oncol ; 5(1): 44, 2021 May 26.
Article de En | MEDLINE | ID: mdl-34040147

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: NPJ Precis Oncol Année: 2021 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Royaume-Uni

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: NPJ Precis Oncol Année: 2021 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: Royaume-Uni